Promino Nutritional Sciences Inc.
MUSL
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -36.38% | 454.11% | 536.70% | 4,288.24% | 1,057.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -36.38% | 454.11% | 536.70% | 4,288.24% | 1,057.32% |
| Cost of Revenue | 23.65% | 27.19% | 568.88% | 1,379.06% | 38,300.00% |
| Gross Profit | -138.90% | 74.97% | 490.84% | 953.77% | 319.38% |
| SG&A Expenses | -19.38% | 149.96% | -55.95% | -69.66% | -76.46% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.83% | 222.92% | -33.36% | -57.21% | -71.43% |
| Operating Income | 2.39% | -174.44% | 73.06% | 73.81% | 79.22% |
| Income Before Tax | 21.11% | -362.21% | 110.71% | 52.41% | 83.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 21.11% | -362.21% | 110.71% | 52.41% | 83.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.11% | -362.21% | 110.71% | 52.41% | 83.32% |
| EBIT | 2.39% | -174.44% | 73.06% | 73.81% | 79.22% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 43.75% | -321.88% | 108.15% | 77.20% | 92.43% |
| Normalized Basic EPS | 15.00% | -236.67% | 76.47% | 78.13% | 92.42% |
| EPS Diluted | 43.75% | -378.13% | 107.48% | 77.20% | 92.43% |
| Normalized Diluted EPS | 15.00% | -236.67% | 76.47% | 78.13% | 92.42% |
| Average Basic Shares Outstanding | 38.75% | 18.77% | 36.49% | 109.84% | 123.88% |
| Average Diluted Shares Outstanding | 38.75% | 18.77% | 36.49% | 109.84% | 123.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |